NICE issues draft recommendation for new kidney disease treatment
Forxiga becomes the first new treatment option for CKD patients in nearly 20 years
Read More
Author: Lucy Parsons
Researchers find HPV vaccine cuts cervical cancer by 87%
The research paper, published in the Lancet and funded by Cancer Research UK, considered all cervical cancers diagnosed in England among women aged 20-64 between January 2006 and June 2019
Read More
UK approval for MSD/Ridgeback’s COVID-19 antiviral med
The antiviral medicine will be marketed with the trademark name Lagevrio in the UK
Read More
Guardant Health and Royal Marsden NHS Foundation Trust announce partnership
Partnership will establish an in-house liquid biopsy testing service, using Guardant Health’s proprietary digital sequencing platform
Read More
NICE recommends Namuscla for NHS to treat genetic disorder
It is estimated that around 250 people will be eligible to have Namuscla
Read More- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
- Theolytics announces first patient dosed in the Octopod‑IP trial
- UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
- Saphnelo approved in the US for subcutaneous self‑administration
- Transgene completes randomisation in phase 2 trial of tg4050
